✦ LIBER ✦

T cell immune response during HBeAG seroconversion? Evidence of T cell activation, cytotoxicity and proliferation during treatment with interferon/thymosin in patients with chronic hepatitis B

✍ Scribed by S. Lim; L. Zhou; L. Li; T. Tan; F. Peter; E. Ren; D.S. Selamat; C. Wai; Y. Lee; L. Lim; S. Chan

Book ID: 119527255
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 140 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)81300-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dynamics of memory T cells during treatm

Dynamics of memory T cells during treatment with interferon-alpha in patients with chronic hepatitis B

✍ Bin Sun; Yanjun Wang; Qinghua Meng; Daojie Liu; Peiling Dong; Huiguo Ding; Hao W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Early decrease of interferon-γ+ and inte

Early decrease of interferon-γ+ and interleukin-2+ T cells during combination treatment with interferon-α and ribavirin in patients with chronic hepatitis C

✍ Mauro Krampera; Giovanna Fattovich; Maria Teresa Scupoli; Giovanni Pizzolo 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Prediction of the response to peg-interf

Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment

✍ Bettina E. Hansen; Erik H.C.J. Buster; Ewout W. Steyerberg; Emmanuel Lesaffre; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract Peginterferon (PEG‐IFN) results in HBeAg loss combined with virologic response in only a minority of patients with HBeAg positive chronic hepatitis B. Baseline predictors of response to PEG‐IFN include HBV‐genotype, pre‐treatment HBV DNA levels, and ALT. The aims of this study were to d

T1983 Endogenous Erythropoietin Response

T1983 Endogenous Erythropoietin Response and Predictive Factors for Anemia During Treatment With PEG-Interferon Alfa-2B and Ribavirin in Chronic Hepatitis C Patients

✍ van Vlerken, Lotte G.; van Soest, Hanneke; Janssen, Mart P.; Boland, Greet J.; D 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Loss of HBsAg antigen during treatment w

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

✍ R. G. Gish; T.-T. Chang; C.-L. Lai; R. De Man; A. Gadano; F. Poordad; J. Yang; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Effect of combined lamivudine and interf

Effect of combined lamivudine and interferon alpha treatment on the T-cell response to HBV core peptides in patients with chronic hepatitis B virus infection

✍ Mhairi Cavers; Marion Aw; Umesh Sharma; Lorenzo D'Antiga; Roger William; Alison 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 221 KB